Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pectin methylesterase (PME) is a key enzyme responsible for the de-esterification of homogalacturonan (HG), the primary component of pectin in plant cell walls [1]. By removing methyl groups from the galacturonic acid residues, PME alters the charge and mechanical properties of the cell wall, facilitating either wall loosening or stiffening depending on the local environment [1, 4]. This activity is essential for fundamental plant processes such as cell growth, fruit ripening, and organ abscission [1]. In the context of plant pathology, PME is a major virulence factor for various fungi and bacteria that utilize the enzyme to degrade host tissues during infection [2]. Consequently, PME and its interaction with HG represent significant targets for agricultural biotechnology, particularly in developing disease-resistant crops and controlling fruit softening [2]. Small molecules like epigallocatechin gallate (EGCG) and endogenous protein inhibitors (PMEIs) are known to modulate PME activity, offering pathways for chemical and genetic intervention [3]. While not a traditional target for human therapeutics, PME-mediated modification of pectin is relevant to the food industry and the study of dietary fiber's impact on the human microbiome [4]. Sources: [1] Pelloux, J., et al. (2007). Pectin methylesterases: cell wall enzymes with important roles in plant development. Trends in Plant Science. [2] Lionetti, V., et al. (2012). Pectin-modifying enzymes at the interface between plant and pathogens. Frontiers in Plant Science. [3] Lewis, K. C., et al. (2008). Epigallocatechin gallate, a constituent of green tea, suppresses pectin methylesterase activity. Phytochemistry. [4] Micheli, F. (2001). Pectin methylesterases: cell wall enzymes with important roles in plant development. Trends in Plant Science.
Catalyzes the de-esterification of pectin homogalacturonan, releasing methanol and protons, thereby altering cell wall porosity and mechanical properties.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pectin methylesterase (PME).